InvestorsHub Logo
Followers 0
Posts 14
Boards Moderated 0
Alias Born 04/27/2018

Re: Bahzzz post# 5435

Monday, 06/18/2018 3:21:11 PM

Monday, June 18, 2018 3:21:11 PM

Post# of 7578
Correction median duration 18.3 months. GERN easily surpasses that number for TI. It's late here and for some reason I keep thinking OS for MDS which doesn't make sense. GERN (Lenalidomide and HMA naïve) median TI duration is 42.9 and all patients is 23.1 both greater than the 18.3 for luspatercept. Remember this is phase 2 data vs phase 3 data, the phase 3 data with control-arm will have better numbers and is already beating it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News